This announcement is a separate document:
诺泰生物：关于江苏诺泰澳赛诺生物制药股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函之回复报告（修订稿）
Nortel Biotech: Response Report to the Audit Inquiry Letter on the Issuance of Convertible Corporate Bonds Application Documents by Jiangsu Nuotai Auxano Biopharmaceutical Co., Ltd. to Unspecified Targets (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated